Mergers & Acquisitions
Biotechnology
London, UK-based Syncona has announced that Freeline Therapeutics has acquired SwanBio Therapeutics to create a new company, Spur Therapeutics.
Today's issue
Refine Search
Latest Mergers & Acquisitions News & Features
Biotechnology
AbbVie, Acquired, Celsius Therapeutics 28 June 2024
Biotechnology
TwoStep Therapeutics, a biotech start-up developing targeted therapies for solid tumors, has officially launched after securing $6.5 million in seed funding. 27 June 2024
Pharmaceutical
CASI Pharmaceuticals (Nasdaq: CASI) has announced a preliminary proposal from its chairman and chief executive, Wei-Wu He, to acquire the company's business operations in China. 27 June 2024
Pharmaceutical
Deal volume was up 20% in the pharmaceutical and life sciences sector in the last 12 months as dealmakers grew more comfortable with uncertainty, according to a 21 June 2024
Pharmaceutical
Vanda Pharma rejects unsolicited takeover bids 20 June 2024
Biotechnology
London’s Syncona has announced that Freeline Therapeutics has acquired SwanBio Therapeutics to create a new company, Spur Therapeutics. 17 June 2024
Pharmaceutical
Syntis Bio, a new clinical-stage biopharmaceutical company, has officially launched. 11 June 2024
Biotechnology
GSK buys Elsie to expand oligonucleotide pipeline 7 June 2024
Pharmaceutical
US healthcare giant Johnson & Johnson continued its M&A spending spree during May. 6 June 2024
Pharmaceutical
Privately-held UK firm Cycle Pharmaceuticals, which is focused on rare diseases, is seeking to acquire US biopharma Vanda Pharmaceuticals. 6 June 2024
Biotechnology
Vilya, a biotechnology company focused on designing novel medicines, has announced a $71 million expansion of its series A financing. 5 June 2024
Biotechnology
The week in pharma: action, reaction and insight – week to May 31, 2024 2 June 2024
Biotechnology
US pharma giant Merck & Co is to buy Eyebiotech, a privately-held New York-based ophthalmology-focused biotech company. 29 May 2024
Biotechnology
Calliditas rockets on news of takeover offer from Asahi Kasei 28 May 2024
Pharmaceutical
Next-gen obesity start-up SixPeaks Bio debuts with $110 million funding 23 May 2024
Biotechnology
Biogen to expand late-stage pipeline with HI-Bio buy 22 May 2024
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze